Skip to main content

Table 5 Patient-related recurrent costs (US$)

From: Costs of a successful public-private partnership for TB control in an urban setting in Nepal

  

Costs

Category of cost

Number of patients reporting non-zero cost

Total reported

Min value

Max value

Per patient per 8 months

 
     

Median

Mean

Expenses with traditional healers

11

305

0

141

0.0

7.0

Diagnosis stage (excluding travel)

      

   Consultation charges

48

196

0

16

1.5

4.5

   Investigations

50

830

0.1

119

7.5

19.0

Sub-Total Diagnosis

 

1,026

0.2

132

10

23.4

Treatment (excluding medicines and travel)

      

   Consultation charges

14

66

0

15

0.0

1.5

   Investigations

31

57

0

12

0.2

1.3

Sub-Total Treatment

 

123

0

27

0.3

2.8

Patients' travel and opportunity costs

      

   Travel expenses

11

184

0

37

0.0

4.2

   Opportunity costs of days lost due to TB

18

5,152

0

1,755

0.0

117.8

   Opportunity costs of travel time

50

842

1.8

202

8.8

19.3

Sub-Total Patients' Travel

 

6,179

2.4

1,780

3.8

141.2

Costs of escorts (travel time lost + cost of travel)

      

   Travel expenses

6

73

0

40

0.0

1.7

   Opportunity costs of travel time

33

146

0

44

0.9

3.3

Sub-Total Costs of Escorts

 

219

0

84

0.9

5.0

Other (miscellaneous) expenditures

5

100

0

36

0.0

2.3

TOTAL PATIENTS' COSTS

 

7,952

  

35.90

181.80

  1. A breakdown of patient-related recurrent costs across main categories is presented. Frequency of costs from the total n = 50 is reported and total reported costs are shown versus median per patient's treatment course.
  2. Note 1: The numbers of patients who reported costs are based on the total sample of 50.
  3. Note 2: Minimum and maximum values and medians were derived for each type of costs separately and sub-totals in these columns are NOT the sums of their respective constituent costs.
  4. Note 3: An increment from 7 months (median of patients' month at which costing data was collected) to 8 months (standard duration of treatment) was used to estimate mean values per patient per 8 months